Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1

HIV-individuals are at risk for human T-lymphotropic virus (HTLV) coinfection and neurological diseases. Little is known about the impact of HAART among coinfected patients. In this study, 47 out of 428 HIV individuals were coinfected with HTLV (10.9%). Coinfection was an independent variable associ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS (London) 2012-02, Vol.26 (4), p.521-523
Hauptverfasser: SILVA, Marcus T. T, NEVES, Elizabeth S, GRINSZTEJN, Beatriz, MELO ESPINDOLA, Otavio De, SCHOR, Doris, ARAUJO, Abelardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 523
container_issue 4
container_start_page 521
container_title AIDS (London)
container_volume 26
creator SILVA, Marcus T. T
NEVES, Elizabeth S
GRINSZTEJN, Beatriz
MELO ESPINDOLA, Otavio De
SCHOR, Doris
ARAUJO, Abelardo
description HIV-individuals are at risk for human T-lymphotropic virus (HTLV) coinfection and neurological diseases. Little is known about the impact of HAART among coinfected patients. In this study, 47 out of 428 HIV individuals were coinfected with HTLV (10.9%). Coinfection was an independent variable associated with neurological outcome (odds ratio 8.73). Coinfection was associated with myelopathy [chi square (X(2)) = 93, P < 0.001], peripheral neuropathy (X(2) = 6.5, P = 0.01), and hepatitis C virus infection (X(2) = 36.5, P < 0.001). HAART did not appear to protect against neurological diseases and had no impact on HTLV proviral load.
doi_str_mv 10.1097/QAD.0b013e32834c4a3e
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954642920</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>921141541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-74866e754d04f05762b2d1e3a79ca091b8229c71d25df80bd6c4d52f3ab08cb43</originalsourceid><addsrcrecordid>eNqFkNFqFTEQhkNR7LH1DUrJjXi1NZNMNslladUWiiK0gldLNpt4UnY322RXOW_vlh4VeuPVMPD9_wwfISfAzoAZ9f7r-eUZaxkIL7gW6NAKf0A2gEpUUip4QTaM16YyQrFD8rqUe8aYZFq_IocctAbUfEO-f_ZLTn36EZ3t6WDHGHyZ7RzTWGgK1KU4Bu8ed_orzlt6df2N2rGj22WF6W3V74Zpm-acpujoz5iXQufd5Ckck5fB9sW_2c8jcvfxw-3FVXXz5dP1xflN5RBwrhTquvZKYscwMKlq3vIOvLDKOMsMtJpz4xR0XHZBs7arHXaSB2Fbpl2L4oi8e-qdcnpY1uebIRbn-96OPi2lMRJr5Iaz_5McAEEirCQ-kS6nUrIPzZTjYPOuAdY82m9W-81z-2vsdH9gaQff_Q390b0Cb_eALavvkO3oYvnHSWnQCCl-A_hvjj4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>921141541</pqid></control><display><type>article</type><title>Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>SILVA, Marcus T. T ; NEVES, Elizabeth S ; GRINSZTEJN, Beatriz ; MELO ESPINDOLA, Otavio De ; SCHOR, Doris ; ARAUJO, Abelardo</creator><creatorcontrib>SILVA, Marcus T. T ; NEVES, Elizabeth S ; GRINSZTEJN, Beatriz ; MELO ESPINDOLA, Otavio De ; SCHOR, Doris ; ARAUJO, Abelardo</creatorcontrib><description>HIV-individuals are at risk for human T-lymphotropic virus (HTLV) coinfection and neurological diseases. Little is known about the impact of HAART among coinfected patients. In this study, 47 out of 428 HIV individuals were coinfected with HTLV (10.9%). Coinfection was an independent variable associated with neurological outcome (odds ratio 8.73). Coinfection was associated with myelopathy [chi square (X(2)) = 93, P &lt; 0.001], peripheral neuropathy (X(2) = 6.5, P = 0.01), and hepatitis C virus infection (X(2) = 36.5, P &lt; 0.001). HAART did not appear to protect against neurological diseases and had no impact on HTLV proviral load.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/QAD.0b013e32834c4a3e</identifier><identifier>PMID: 21881482</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>AIDS/HIV ; Antiretroviral Therapy, Highly Active ; Biological and medical sciences ; CD4 Lymphocyte Count ; Coinfection ; Deltaretrovirus Antibodies - blood ; Female ; Hepatitis C Antibodies - blood ; Hepatitis C virus ; HIV Infections - complications ; HIV Infections - physiopathology ; HTLV-II Infections - complications ; HTLV-II Infections - physiopathology ; Human immunodeficiency virus ; Human T-lymphotropic virus ; Human T-lymphotropic virus 1 - pathogenicity ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Odds Ratio ; Peripheral Nervous System Diseases - physiopathology ; Peripheral Nervous System Diseases - virology ; Spinal Cord Diseases - virology ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral Load</subject><ispartof>AIDS (London), 2012-02, Vol.26 (4), p.521-523</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-74866e754d04f05762b2d1e3a79ca091b8229c71d25df80bd6c4d52f3ab08cb43</citedby><cites>FETCH-LOGICAL-c414t-74866e754d04f05762b2d1e3a79ca091b8229c71d25df80bd6c4d52f3ab08cb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25594935$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21881482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SILVA, Marcus T. T</creatorcontrib><creatorcontrib>NEVES, Elizabeth S</creatorcontrib><creatorcontrib>GRINSZTEJN, Beatriz</creatorcontrib><creatorcontrib>MELO ESPINDOLA, Otavio De</creatorcontrib><creatorcontrib>SCHOR, Doris</creatorcontrib><creatorcontrib>ARAUJO, Abelardo</creatorcontrib><title>Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>HIV-individuals are at risk for human T-lymphotropic virus (HTLV) coinfection and neurological diseases. Little is known about the impact of HAART among coinfected patients. In this study, 47 out of 428 HIV individuals were coinfected with HTLV (10.9%). Coinfection was an independent variable associated with neurological outcome (odds ratio 8.73). Coinfection was associated with myelopathy [chi square (X(2)) = 93, P &lt; 0.001], peripheral neuropathy (X(2) = 6.5, P = 0.01), and hepatitis C virus infection (X(2) = 36.5, P &lt; 0.001). HAART did not appear to protect against neurological diseases and had no impact on HTLV proviral load.</description><subject>AIDS/HIV</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Biological and medical sciences</subject><subject>CD4 Lymphocyte Count</subject><subject>Coinfection</subject><subject>Deltaretrovirus Antibodies - blood</subject><subject>Female</subject><subject>Hepatitis C Antibodies - blood</subject><subject>Hepatitis C virus</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - physiopathology</subject><subject>HTLV-II Infections - complications</subject><subject>HTLV-II Infections - physiopathology</subject><subject>Human immunodeficiency virus</subject><subject>Human T-lymphotropic virus</subject><subject>Human T-lymphotropic virus 1 - pathogenicity</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Odds Ratio</subject><subject>Peripheral Nervous System Diseases - physiopathology</subject><subject>Peripheral Nervous System Diseases - virology</subject><subject>Spinal Cord Diseases - virology</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral Load</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkNFqFTEQhkNR7LH1DUrJjXi1NZNMNslladUWiiK0gldLNpt4UnY322RXOW_vlh4VeuPVMPD9_wwfISfAzoAZ9f7r-eUZaxkIL7gW6NAKf0A2gEpUUip4QTaM16YyQrFD8rqUe8aYZFq_IocctAbUfEO-f_ZLTn36EZ3t6WDHGHyZ7RzTWGgK1KU4Bu8ed_orzlt6df2N2rGj22WF6W3V74Zpm-acpujoz5iXQufd5Ckck5fB9sW_2c8jcvfxw-3FVXXz5dP1xflN5RBwrhTquvZKYscwMKlq3vIOvLDKOMsMtJpz4xR0XHZBs7arHXaSB2Fbpl2L4oi8e-qdcnpY1uebIRbn-96OPi2lMRJr5Iaz_5McAEEirCQ-kS6nUrIPzZTjYPOuAdY82m9W-81z-2vsdH9gaQff_Q390b0Cb_eALavvkO3oYvnHSWnQCCl-A_hvjj4</recordid><startdate>20120220</startdate><enddate>20120220</enddate><creator>SILVA, Marcus T. T</creator><creator>NEVES, Elizabeth S</creator><creator>GRINSZTEJN, Beatriz</creator><creator>MELO ESPINDOLA, Otavio De</creator><creator>SCHOR, Doris</creator><creator>ARAUJO, Abelardo</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20120220</creationdate><title>Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1</title><author>SILVA, Marcus T. T ; NEVES, Elizabeth S ; GRINSZTEJN, Beatriz ; MELO ESPINDOLA, Otavio De ; SCHOR, Doris ; ARAUJO, Abelardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-74866e754d04f05762b2d1e3a79ca091b8229c71d25df80bd6c4d52f3ab08cb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>AIDS/HIV</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Biological and medical sciences</topic><topic>CD4 Lymphocyte Count</topic><topic>Coinfection</topic><topic>Deltaretrovirus Antibodies - blood</topic><topic>Female</topic><topic>Hepatitis C Antibodies - blood</topic><topic>Hepatitis C virus</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - physiopathology</topic><topic>HTLV-II Infections - complications</topic><topic>HTLV-II Infections - physiopathology</topic><topic>Human immunodeficiency virus</topic><topic>Human T-lymphotropic virus</topic><topic>Human T-lymphotropic virus 1 - pathogenicity</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Odds Ratio</topic><topic>Peripheral Nervous System Diseases - physiopathology</topic><topic>Peripheral Nervous System Diseases - virology</topic><topic>Spinal Cord Diseases - virology</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SILVA, Marcus T. T</creatorcontrib><creatorcontrib>NEVES, Elizabeth S</creatorcontrib><creatorcontrib>GRINSZTEJN, Beatriz</creatorcontrib><creatorcontrib>MELO ESPINDOLA, Otavio De</creatorcontrib><creatorcontrib>SCHOR, Doris</creatorcontrib><creatorcontrib>ARAUJO, Abelardo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SILVA, Marcus T. T</au><au>NEVES, Elizabeth S</au><au>GRINSZTEJN, Beatriz</au><au>MELO ESPINDOLA, Otavio De</au><au>SCHOR, Doris</au><au>ARAUJO, Abelardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2012-02-20</date><risdate>2012</risdate><volume>26</volume><issue>4</issue><spage>521</spage><epage>523</epage><pages>521-523</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>HIV-individuals are at risk for human T-lymphotropic virus (HTLV) coinfection and neurological diseases. Little is known about the impact of HAART among coinfected patients. In this study, 47 out of 428 HIV individuals were coinfected with HTLV (10.9%). Coinfection was an independent variable associated with neurological outcome (odds ratio 8.73). Coinfection was associated with myelopathy [chi square (X(2)) = 93, P &lt; 0.001], peripheral neuropathy (X(2) = 6.5, P = 0.01), and hepatitis C virus infection (X(2) = 36.5, P &lt; 0.001). HAART did not appear to protect against neurological diseases and had no impact on HTLV proviral load.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>21881482</pmid><doi>10.1097/QAD.0b013e32834c4a3e</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-9370
ispartof AIDS (London), 2012-02, Vol.26 (4), p.521-523
issn 0269-9370
1473-5571
language eng
recordid cdi_proquest_miscellaneous_954642920
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects AIDS/HIV
Antiretroviral Therapy, Highly Active
Biological and medical sciences
CD4 Lymphocyte Count
Coinfection
Deltaretrovirus Antibodies - blood
Female
Hepatitis C Antibodies - blood
Hepatitis C virus
HIV Infections - complications
HIV Infections - physiopathology
HTLV-II Infections - complications
HTLV-II Infections - physiopathology
Human immunodeficiency virus
Human T-lymphotropic virus
Human T-lymphotropic virus 1 - pathogenicity
Human viral diseases
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infectious diseases
Male
Medical sciences
Middle Aged
Odds Ratio
Peripheral Nervous System Diseases - physiopathology
Peripheral Nervous System Diseases - virology
Spinal Cord Diseases - virology
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral Load
title Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T00%3A50%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurological%20manifestations%20of%20coinfection%20with%20HIV%20and%20human%20T-lymphotropic%20virus%20type%201&rft.jtitle=AIDS%20(London)&rft.au=SILVA,%20Marcus%20T.%20T&rft.date=2012-02-20&rft.volume=26&rft.issue=4&rft.spage=521&rft.epage=523&rft.pages=521-523&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/QAD.0b013e32834c4a3e&rft_dat=%3Cproquest_cross%3E921141541%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=921141541&rft_id=info:pmid/21881482&rfr_iscdi=true